Lekoklar

Clarithromycin, the active ingredient in Lekoklar, is a macrolide presented as an oral tablet for systemic use. It treats bacterial infections such as community‑acquired pneumonia, acute bacterial sinusitis, skin and soft‑tissue infections, and is used in Helicobacter pylori eradication regimens. GNH USA supplies Lekoklar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Clarithromycin is a macrolide antibiotic indicated for several bacterial infections. - Community‑acquired pneumonia: resolves infection and improves respiratory function. - Acute bacterial sinusitis: reduces sinus inflammation and clears pathogenic bacteria. - Skin and soft‑tissue infections: eradicates susceptible Gram‑positive and some Gram‑negative organisms. - Helicobacter pylori eradication: part of combination therapy to eliminate H. pylori infection.

Clarithromycin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: frequent loose stools. - Abdominal pain: cramping or discomfort. - Taste disturbance: altered or metallic taste. - Headache: mild headache episodes. - Rash: mild skin erythema.

Serious or Rare Side Effects: - Hepatotoxicity: elevated liver enzymes or jaundice. - QT prolongation: cardiac rhythm disturbances. - Severe allergic reaction: anaphylaxis or angioedema. - Clostridioides difficile infection: severe colitis. - Hematologic abnormalities: neutropenia or thrombocytopenia.

Before initiating therapy, consider patient‑specific factors and monitor for adverse events. - Assess liver function: evaluate hepatic enzymes prior to and during treatment. - Evaluate cardiac risk: avoid in patients with known QT prolongation or electrolyte imbalance. - Review drug history: check for concomitant use of CYP3A4 inhibitors. - Monitor renal function: adjust in severe renal impairment if needed. - Counsel on gastrointestinal symptoms: advise hydration and diet modifications. - Store below 25°C: keep in the original pack, protect from moisture.

Clarithromycin interacts with several drug classes; some require avoidance while others need close monitoring.

Major Interactions (Avoid): - Statins (e.g., simvastatin, lovastatin): risk of rhabdomyolysis. - Certain antiarrhythmics (e.g., amiodarone): increased QT prolongation. - Ergot derivatives: risk of severe vasospasm.

Moderate Interactions (Monitor Closely): - Warfarin: enhanced anticoagulant effect, monitor INR. - Theophylline: increased plasma levels, watch for toxicity. - Carbamazepine: reduced efficacy of carbamazepine, monitor seizures.